BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A von Konkle, Barbara A, Shapiro, Amy D, Quon, Doris V, Staber, Janice M, Kulkarni, Roshni, Ragni, Margaret V, Chhabra, Ekta S, Poloskey, Stacey, Rice, Kara, Katragadda, Suresh, Fruebis, Joachim, Benson, Craig C

Volltext

Sutimlimab in Cold Agglutinin Disease von Röth, Alexander, Barcellini, Wilma, D’Sa, Shirley, Miyakawa, Yoshitaka, Broome, Catherine M, Michel, Marc, Kuter, David J, Jilma, Bernd, Tvedt, Tor H.A, Fruebis, Joachim, Jiang, Xiaoyu, Lin, Stella, Reuter, Caroline, Morales-Arias, Jaime, Hobbs, William, Berentsen, Sigbjørn

Volltext

Proteolytic Cleavage Product of 30-kDa Adipocyte Complement-Related Protein Increases Fatty Acid Oxidation in Muscle and Causes Weight Loss in Mice von Fruebis, Joachim, Tsao, Tsu-Shuen, Javorschi, Sandrine, Ebbets-Reed, Dana, Mary Ruth S. Erickson, Yen, Frances T., Bihain, Bernard E., Lodish, Harvey F.

Volltext

ACRP30, a new hormone controlling fat and glucose metabolism von Tsao, Tsu-Shuen, Lodish, Harvey F., Fruebis, Joachim

Volltext

Recombinant factor VIII Fc fusion protein for the treatment of severe haemophilia A: Final results from the ASPIRE extension study von Nolan, Beatrice, Mahlangu, Johnny, Pabinger, Ingrid, Young, Guy, Konkle, Barbara A., Barnes, Chris, Nogami, Keiji, Santagostino, Elena, Pasi, K. John, Khoo, Liane, Winding, Bent, Yuan, Huixing, Fruebis, Joachim, Rudin, Dan, Oldenburg, Johannes

Volltext

Effect of Probucol Treatment on Gene Expression of VCAM-1, MCP-1, and M-CSF in the Aortic Wall of LDL Receptor-Deficient Rabbits During Early Atherogenesis von Fruebis, Joachim, Gonzalez, Virginia, Silvestre, Mercedes, Palinski, Wulf

Volltext

Long‐term safety and sustained efficacy for up to 5 years of treatment with recombinant factor IX Fc fusion protein in subjects with haemophilia B: Results from the B‐YOND extensio... von Pasi, K. John, Fischer, Kathelijn, Ragni, Margaret, Kulkarni, Roshni, Ozelo, Margareth C., Mahlangu, Johnny, Shapiro, Amy, P’Ng, Stephanie, Chambost, Hervé, Nolan, Beatrice, Bennett, Carolyn, Matsushita, Tadashi, Winding, Bent, Fruebis, Joachim, Yuan, Huixing, Rudin, Dan, Oldenburg, Johannes

Volltext

PDE-9 Inhibition Combined with Hydroxyurea Is Beneficial in Vaso-Occlusive Crisis in Mouse Model of Sickle Cell Disease von Jasuja, Reema, Hett, Sunita Patel, Fruebis, Joachim, Pittman, Debra

Volltext

BIVV001: The First Investigational Factor VIII Therapy to Break Through the VWF Ceiling in Hemophilia A, with Potential for Extended Protection for One Week or Longer von Konkle, Barbara A, Shapiro, Amy, Quon, Doris, Staber, Janice, Suzuki, Takashi, Poloskey, Stacey, Rice, Kara, Katragadda, Suresh, Rudin, Dan, Fruebis, Joachim

Volltext

Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice von Bird, D A, Tangirala, R K, Fruebis, J, Steinberg, D, Witztum, J L, Palinski, W

Volltext

Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits von Fruebis, J, Silvestre, M, Shelton, D, Napoli, C, Palinski, W

Volltext

A Zymogen-like Factor Xa Improves Hemostasis in a Murine Bleeding Model von Reema, Jasuja, Patel-Hett, Sunita, Camire, Rodney M., Fruebis, Joachim, Pittman, Debra

Volltext

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo von Thalji, Nabil K., Ivanciu, Lacramioara, Jasuja, Reema, Patel-Hett, Sunita, Fruebis, Joachim, Pittman, Debra, Camire, Rodney M.

Volltext

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors von Thalji, Nabil K, Patel-Hett, Sunita, Jasuja, Reema, Fruebis, Joachim, Pittman, Debra, Camire, Rodney M.

Volltext

C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen von Lasser, Gerald, Guchhait, Prasenjit, Ellsworth, Jeff L., Sheppard, Paul, Lewis, Ken, Bishop, Paul, Cruz, Miguel A., Lopez, Jose A., Fruebis, Joachim

Volltext

A Novel FVIIa Variant with Increased Potency and Duration of Effect Compared to Wildtype FVIIa. A Study in a Dog Model of Hemophilia A von Pittman, Debra, Weston, Stacey, Shields, Kathleen, Parng, Chuenlei, Arkin, Steven, Madison, Ed, Nichols, Timothy C., Fruebis, Joachim

Volltext

Evidence for a Concerted Reaction Between Lipid Hydroperoxides and Polypeptides von Fruebis, Joachim, Parthasarathy, Sampath, Steinberg, Daniel

Volltext

Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants von Fruebis, J, Bird, D.A, Pattison, J, Palinski, W

Volltext

A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits von Fruebis, J, Steinberg, D, Dresel, H A, Carew, T E

Volltext

Effect of aging on aortic expression of the vascular cell adhesion molecule-1 and atherosclerosis in murine models of atherosclerosis von Merat, S, Fruebis, J, Sutphin, M, Silvestre, M, Reaven, P D

Volltext